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Abstract
Cerebral angioinvasion is a fatal complication of disseminated aspergillosis and has been rarely
described in diabetic population in the absence of ketoacidosis. We present a case of invasive fungal
sinusitis in a 79 year old diabetic man who presented with chronic frontal headaches. Despite
appropriate medical and surgical treatment, the disease progressed and the patient eventually
succumbed to a fatal ruptured mycotic aneurysm. We emphasize that clinicians should consider this
in the differential diagnoses of all diabetics who present with chronic sinusitis, as early diagnosis
could be the key in the successful treatment.
Introduction
Invasive cerebral aspergillosis is a rare manifestation of
disseminated aspergillosis and is associated with high
mortality rates. Ruptured mycotic aneurysm and sub-
arachnoid hemorrhage are uncommon but devastating
complications in invasive cerebral aspergillosis. The dis-
ease entity has been described in immunocompromised
patients, but has only rarely been reported in diabetic
patients. Chronic fungal sinusitis should be recognized as
an early sign of possible aspergillosis and often presents
with new-onset, persistent headaches. The ability of
Aspergillus to attack blood vessels leading to necrotizing
angiitis, secondary thrombosis, and hemorrhage, is a
characteristic angioinvasive feature and thereby makes
insidious aspergillosis an important consideration in per-
sons manifesting with acute onset of focal neurologic def-
icits, including immunocompetent patients in the correct
clinical setting. We present a fatal case report of a 79-year-
old diabetic man who presented with relentless headaches
who was found to have chronic sphenoid fungal sinusitis.
Despite treatment, he eventually succumbed to a ruptured
mycotic aneurysm that was the result of direct extension
from chronic Aspergillus sinusitis to the intracerebral circu-
lation.
Case presentation
A 79-year-old man of Egyptian descent presented to the
emergency department (ED) with complaints of chronic
frontal headaches worsening over the last 2 weeks. The
patient had a past medical history of hypertension, insu-
lin-dependent diabetes mellitus, prostate cancer status-
post prostatectomy, and osteoarthritis. He denied any his-
tory of steroid use or any chemotherapy. He denied recent
travel. He had immigrated to the USA from Egypt eleven
years before. He denied smoking, alcohol, or illicit drug
use. He denied any allergies.
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The history goes back one year prior when he began expe-
riencing intermittent frontal headaches. Initially he
underwent ophthalmologic evaluation which was nor-
mal. His symptoms progressed over the following
months. He was evaluated several times in the ED during
this time but workup was unrevealing. His headache had
dramatically worsened 2 weeks ago accompanied by fever,
malaise, nausea, vomiting and decreased appetite. He
went to his primary medical doctor and was started on
clarithromycin as an outpatient for the treatment of pre-
sumed otitis media. The symptoms did not improve after
5 days of antibiotics and the patient came to the ED.
Vital signs in the ED were temperature of 100.4°F, pulse
of 106 bpm, blood pressure 159/64 mmHg, and 18
breaths/min. Physical examination was notable for bilat-
eral tenderness over the maxillary and frontal sinuses.
There was no nuchal rigidity and the extra-ocular muscles
were intact. The rest of the physical exam was unremarka-
ble. A complete blood count revealed a white blood cell
count of 7700 cells/mm3; hemoglobin of 15 mg/dL; and
platelet count of 182,000/mm3. The erythrocyte sedimen-
tation rate (ESR) was 1. The basic metabolic panel was
within normal limits. Initial chest x-ray revealed no acute
infiltrates. Computed tomography of the head showed
complete opacification of the sphenoid sinuses with loss
of adjacent walls in the region of the spheno-ethmoidal
recesses showing aggressive chronic sinusitis. Computed
tomography of the maxillofacial sinuses revealed pansi-
nusitis with complete opacification of bilateral sphenoid
sinuses and thickening of the sphenoid sinuses consistent
with chronic sinusitis. Magnetic Resonance Imaging
(MRI) of the head confirmed the findings of the CT scans.
Magnetic Resonance Angiogram (MRA) was also per-
formed which ruled out the presence any aneurysm or ste-
nosis in the CNS vasculature. Magnetic Resonance
Venography (MRV) was also performed for the presence
of cavernous sinus thrombosis, which was negative. For
CT Scan on admission showing opacification of the sphe-
noid sinuses see Figure 1.
Lumbar puncture was done which showed a clear, color-
less CSF with RBC count of 136/mm3 and WBC count of
8/mm3. The differential comprised of 80% neutrophils,
10% lymphocytes and 10% monocytes. The CSF chemis-
try revealed glucose of 70 mg/dl (serum level: 164 mg/dl);
protein of 154 mg/dl; and chloride of 125 mg/dl. Gram
staining, culture and India ink stain of the CSF were all
negative. Based upon these findings, notably the presence
of neutrophils in the CSF, a diagnosis of possible bacterial
meningitis was made and the patient was started on intra-
venous vancomycin, ceftriaxone, as well as acyclovir, and
was admitted.
While on the medical ward, the patient continued to have
persistent headaches. An EEG was conducted and showed
no evidence of encephalopathy or epileptiform activity.
Interim blood cultures were negative for growth. Fungal
blood cultures were also negative. Serum crytptococcal
antigen and Lyme antibodies were unremarkable. To fur-
ther aide with the diagnosis, the otorhinolaryngology
service was consulted. Subsequently, he underwent endo-
scopic drainage of the sphenoid sinuses, which removed a
significant amount of yellow, mucopurulent material. The
specimen was sent to pathology for analysis. The patient
reported a dramatic improvement of the headaches after
the procedure and was afebrile. He was discharged home
on clindamycin and ciprofloxacin, in addition to his rou-
tine medications.
In the interim two days, the pathology report of the sinus
specimen was completed and was significant for marked
chronic sinusitis with large collections of septate, branch-
ing fungi. Fungal stains identified the organisms most
consistent with Aspergillus species, present focally within
the soft tissue of the sinuses. No organisms were specifi-
cally seen invading blood vessels. Further fungal cultures
for species identification were not carried out. The patient
was contacted at home and advised to return to the hospi-
tal for treatment of fungal sinusitis. He returned and was
started on antifungal therapy with intravenous liposomal
amphoterecin B (L-AMB), 500 mg every 24 hours. After a
few days of receiving L-AMB, he developed acute renal
failure. As a result, L-AMB was switched to intravenous
voriconazole 500 mg every 12 hours times 2 doses and
then 300 mg every 24 hours. Following this, he began
experiencing visual hallucinations, likely due to the anti-
fungal azole. Over the next several days, the patient
CT Scan on admission showing opacification of the sphenoid  sinuses Figure 1
CT Scan on admission showing opacification of the 
sphenoid sinuses.Cases Journal 2009, 2:9406 http://www.casesjournal.com/content/2/1/9406
Page 3 of 5
(page number not for citation purposes)
reported feeling better and subsequently he was dis-
charged on oral voriconazole 200 mg every 12 hours for
three weeks. The patient was assessed at follow-up at the
end of the three weeks. The patient reported improvement
in symptoms gradually over time and a repeat CT scans of
the head and sinuses showed clearance of the sinuses. For
specimen from sphenoid sinus fixed with H & E stain
showing fungal hyphae see Figure 2. See Figure 3 for Spec-
imen from sphenoid sinus fixed with PAS stain demon-
strating aspergillus.
Two months later, the patient returned to the ED with
severe frontal headache for the previous ten days. He also
experienced diminished vision of his left eye. Jaw claudi-
cation, photophobia, and nausea were also reported. Fur-
ther questioning revealed that the patient had gone to
another medical institution and was discharged on oral
prednisone for presumed temporal arteritis. Blood work
was obtained; the patient was started on intravenous dex-
amethasone and admitted for additional workup. The ESR
was 38.
On the medical floor, the patient continued to complain
of relentless, worsening headache now associated with
bilateral vision diminishment. He was assessed by the
neurology and ophthalmology services. The steroid dose
was increased. During the following afternoon, the
patient was found unresponsive. The patient had no cor-
neal reflexes, no response to noxious stimuli, and fixed,
dilated, non-reactive pupils bilaterally. He had no doll's
eyes movements. A stroke code protocol was initiated and
the patient was intubated for airway protection. Emergent
CT scan of the head showed diffuse subarachnoid hemor-
rhage with a left temporal lobe hematoma and extensive
intraventricular hemorrhage. The patient was transferred
to the ICU for further management. A repeat CT scan of
the head 24 hours later indicated increase in size of the
subarachnoid hemorrhage and acute ischemic changes in
the distribution of the left middle cerebral artery. The crit-
ical condition of the patient did not allow for evaluation
with MRI/MRA studies or neurosurgical intervention.
Despite aggressive supportive care, the patient expired five
days later. An autopsy request was declined by the
patient's family.
Discussion
The development of cerebral hemorrhage signifies a seri-
ous complication of invasive fungal infections of the CNS
- burst mycotic aneurysms. As the MRA was normal on the
first visit to the hospital, and there was no other obvious
precipitating factor for the hemorrhage, we strongly sus-
pect the development of a ruptured mycotic aneurysm
due to cerebral aspergillosis from direct extension of
chronic sphenoid fungal sinusitis, as the most likely cause
of the patient's acute demise.
Cerebral angioinvasive aspergillosis is a rare manifesta-
tion of disseminated aspergillosis which may result in cer-
ebrovascular accidents in immunocompromised persons,
especially those with hematologic malignancies and
solid-organ transplants. However, reports of such mani-
festations in patients with diabetes mellitus are rare [1],
thus making our patient an atypical subject. Because the
initial chest radiograph was normal in our patient, the
fungal dissemination in this patient likely occurred from
the paranasal sinuses. This is another atypical facet in this
case, as cerebral invasive aspergillosis is usually hematog-
Specimen from sphenoid sinus fixed with H & E stain showing  fungal hyphae Figure 2
Specimen from sphenoid sinus fixed with H & E stain 
showing fungal hyphae.
Specimen from sphenoid sinus fixed with PAS stain demon- strating aspergillus Figure 3
Specimen from sphenoid sinus fixed with PAS stain 
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enously spread from the lungs or GI tract, rather than
from direct extension of sinonasal disease [2].
Invasive cerebral aspergillosis is a catastrophic disease,
with a high mortality rate of 85%-100%, despite antifun-
gal treatment. It is estimated to occur in 10%-15% of
patients with disseminated aspergillosis [3]. Aspergillus
species cause an infective vasculopathy leading initially to
acute infarction or hemorrhage, and subsequently extend-
ing into surrounding tissue as an infectious cerebritis
which may evolve into an abscess. Hyphal elements can
grow through an artery, thereby damaging the composi-
tion of the vessel wall, leading to the development of
mycotic aneurysms [4], of the larger arteries, which can
rupture and cause massive hemorrhage. The location of
the hematoma in this case, in the temporal lobe, goes in
favor of mycotic aneurysm rather than that seen usually
with berry aneurysms [5].
The clinical diagnosis of cerebral aspergillosis is difficult
because the presenting symptoms are nonspecific and
fever may be absent. Patient may present with signs and
symptoms of sinusitis and in advanced cases, proptosis,
cranial nerve palsies, visual deterioration and chemosis
may become evident. Cerebral aspergillosis may present
with meningitis, cerebritis, infarction, abscess, granu-
loma, mycotic aneurysms, or solitary mass-like lesion. The
most frequent pathologic manifestation is hemorrhagic
infarction and abscess [6].
The diagnosis of aspergillosis of the CNS is difficult and is
based on a combination of clinical risks, symptoms and
signs, culture, histopathology, and detection of fungal
components, such as galactomannan or beta-D-glucan
[7]. Histological studies done on specimens taken directly
from the sinuses may reveal faintly visible characteristic
branching septate hyphae at 45° on direct microscopy
with H & E stain, but are more readily seen with Gomori's
methenamine silver (GMS) stain [8]. Histopathologic
studies in acute invasive fungal sinusitis reveal hyphal
invasion of the mucosa, submucosa, and blood vessels,
including the carotid arteries and cavernous sinuses; vas-
culitis with thrombosis; hemorrhage; and tissue infarc-
tion. The culture of Aspergillus  spp is becoming
increasingly important, given the emergence of antifungal
drug-resistant non-fumigatus Aspergillus spp, as well as ris-
ing frequency of other molds causing invasive disease [9].
Surgery remains the mainstay of treatment in all forms of
invasive fungal sinusitis. Aggressive neurosurgical inter-
vention for surgical removal of any abscess, granulomas,
focally infracted brain tissue, and correction of underlying
risk factors are important. If the infection is known to be
due to Aspergillus spp, voriconazole should be initiated
[10]. The efficacy of voriconazole as primary therapy has
been established in clinical trials for invasive aspergillosis
[11].
This case report suggests that a mycotic aneurysm was the
result of the direct extension of chronic Aspergillus sinusi-
tis to the intracerebral circulation in an immunocompe-
tent patient. The implications of this case are noteworthy
for several reasons. Chronic sinusitis should be recog-
nized as an early sign of possible aspergillosis and often
presents with new-onset, persistent headaches. Our
patient had also been taking oral prednisone as an outpa-
tient and was placed on intravenous dexamethasone prior
to his deterioration. The steroids may have been a contrib-
uting factor to the overall disease progression. In a recent
study, Orciuolo et al, showed that the combination of
methylprednisolone therapy and local production of glio-
toxin (a mycotoxin produced by Aspergillus fumigatus)
may contribute to increased inflammatory response lead-
ing to tissue injury and impaired T-cell immune response,
which may be associated with increased morbidity and
mortality in cases of invasive aspergillosis [12]. Almost all
immunocompetent patients with cerebral aspergillosis in
the literature have had the predisposing factors of old age,
diabetes, alcoholism, hepatic failure, drug addiction,
post-surgical sequelae, or post-traumatic events - many of
these risk factors our patient had. This is especially impor-
tant in diabetic patients which comprise a large portion of
our patient population. Also of note was our patient's
Egyptian descent. Chronic invasive sinonasal aspergillosis
has been documented in immunocompetent patients liv-
ing in dry-air climates, similar to the weather found in
Egypt, such as Sudan, Saudi Arabia, and India [13]. A
major reason for the devastating prognosis in cerebral
aspergillosis is the delay in the diagnosis. High degree of
suspicion of disease is needed, prompt use of imaging and
initiation of antifungal therapy are potentially life-pre-
serving tactics because of the difficulty in avoiding a disas-
trous outcome with invasive cerebral aspergillosis once
vascular involvement has occurred.
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